Skip to main content
logo
Barinthus Biotherapeutics plc (BRNS)
Sep 9, 2026 - BRNS was delisted (reason: merged with CLYD)
0.7401
0.00 (0.00%)
Inactive · Last trade price on Sep 8, 2026

Barinthus Biotherapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-41.77-66.43-61.07-73.355.34-50.87
Depreciation & Amortization
0.892.852.62.231.120.4
Other Amortization
2.633.23.23.20.2
Loss (Gain) From Sale of Assets
-0.03-0.25---0.35-
Asset Writedown & Restructuring Costs
5.795.7917.47---
Stock-Based Compensation
1.270.474.715.069.8816.49
Other Operating Activities
0.076.951.565.77-28.18.37
Change in Accounts Receivable
---5.8-5.830.56
Change in Accounts Payable
-1.2-2.20.9-3.381.14-3.53
Change in Unearned Revenue
-1.22-0.511.74--0.18-0.06
Change in Other Net Operating Assets
7.172.35-0.043.75-0.65-4.15
Operating Cash Flow
-26.43-47.98-28.94-50.93-14.43-32.58
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
--0.04-0.89-5.41-6.14-1.15
Sale of Property, Plant & Equipment
0.570.45--0.39-
Cash Acquisitions
------11.77
Investing Cash Flow
0.570.42-0.89-5.41-5.75-12.91

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Repaid
-----0.16-
Total Debt Repaid
-----0.16-
Net Debt Issued (Repaid)
-----0.16-
Issuance of Common Stock
-02.162.040.48102.77
Other Financing Activities
----0.16--5.27
Financing Cash Flow
-02.161.870.33222.74

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-2.37.01-2.022.170.19-6.46
Net Cash Flow
-28.15-40.55-29.69-52.3-19.67170.79

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-26.43-48.02-29.83-56.34-20.57-33.73
Free Cash Flow Growth
------
Free Cash Flow Margin
---199.29%-7024.69%-46.01%-12585.45%
Free Cash Flow Per Share
-0.65-1.19-0.76-1.47-0.54-1.30
Levered Free Cash Flow
-6.17-28.04-16.29-42.351.64-16.54
Unlevered Free Cash Flow
-6.14-28.01-16.26-42.331.65-14.87

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
-----1.84
Cash Income Tax Paid
-----0.15
Change in Working Capital
4.75-0.362.66.17-5.52-7.18
SEC Filings: 10-K · 10-Q